PLUS THERAPEUTICS, INC. Quarterly Interest Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Plus Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q2 2024.
  • Plus Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $27K, a 75.9% decline year-over-year.
  • Plus Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $210K, a 63.7% decline year-over-year.
  • Plus Therapeutics, Inc. annual Interest Expense for 2023 was $395K, a 44.4% decline from 2022.
  • Plus Therapeutics, Inc. annual Interest Expense for 2022 was $711K, a 23.7% decline from 2021.
  • Plus Therapeutics, Inc. annual Interest Expense for 2021 was $932K, a 15.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $210K $27K -$85K -75.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $295K $34K -$100K -74.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $395K $62K -$97K -61% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $492K $87K -$86K -49.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $578K $112K -$69K -38.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $647K $134K -$64K -32.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $711K $159K -$65K -29% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $776K $173K -$59K -25.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $835K $181K -$48K -21% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $883K $198K -$49K -19.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-20
Q4 2021 $932K $224K -$29K -11.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $961K $232K -$21K -8.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-20
Q2 2021 $982K $229K -$23K -9.13% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-21
Q1 2021 $1.01M $247K -$102K -29.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q4 2020 $1.11M $253K -$124K -32.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.23M $253K -$113K -30.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-21
Q2 2020 $1.34M $252K -$345K -57.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $1.69M $349K -$166K -32.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $1.86M $377K -$165K -30.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-22
Q3 2019 $2.02M $366K -$147K -28.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-22
Q2 2019 $2.17M $597K +$153K +34.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.01M $515K +$92K +21.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $1.92M $542K +$96K +21.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.83M $513K +$39K +8.23% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.79M $444K -$94K -17.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 $1.88M $423K -$168K -28.4% Jan 1, 2018 Mar 31, 2018 8-K 2019-09-10
Q4 2017 $2.05M $446K -$199K -30.9% Oct 1, 2017 Dec 31, 2017 8-K 2019-09-10
Q3 2017 $2.25M $474K -$171K -26.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.42M $538K -$107K -16.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.53M $591K -$66K -10% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $2.59M $645K -$57K -8.12% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $2.65M $645K -$24K -3.59% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.67M $645K -$291K -31.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $2.96M $657K -$415K -38.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $3.38M $702K -$383K -35.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 $3.76M $669K -$591K -46.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $4.35M $936K -$149K -13.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $4.5M $1.07M +$131K +13.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $4.37M $1.09M +$144K +15.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 $4.23M $1.26M +$166K +15.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $4.06M $1.09M +$433K +66.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.63M $941K +$232K +32.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $3.4M $941K +$137K +17% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $3.26M $1.09M +$237K +27.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $3.02M $652K -$208K -24.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $3.23M $709K -$156K -18% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $3.39M $804K -$57K -6.62% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $3.44M $857K +$368K +75.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $3.08M $860K +$164K +23.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $2.91M $865K +$127K +17.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $2.78M $861K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 $489K -$270K -35.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $696K +$442K +174% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $738K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $759K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $254K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.